Combined local and systemic bleomycin administration in electrochemotherapy to reduce the number of treatment sessions

BACKGROUND: Electrochemotherapy (ECT), a medical treatment widely used in human patients for tumor treatment, increases bleomycin toxicity by 1000 fold in the treated area with an objective response rate of around 80%. Despite its high response rate, there are still 20% of cases in which the patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Maglietti, Felipe, Tellado, Matias, Olaiz, Nahuel, Michinski, Sebastian, Marshall, Guillermo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4825340/
https://www.ncbi.nlm.nih.gov/pubmed/27069450
http://dx.doi.org/10.1515/raon-2016-0015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4825340/
https://www.ncbi.nlm.nih.gov/pubmed/27069450
http://dx.doi.org/10.1515/raon-2016-0015

Ejemplares similares